Prediagnostic plasma vitamin B6 (pyridoxal 5′-phosphate) and survival in patients with colorectal cancer
Lee, Jung Eun
Fuchs, Charles S.
MetadataShow full item record
CitationJe, Youjin, Jung Eun Lee, Jing Ma, Xuehong Zhang, Eunyoung Cho, Bernard Rosner, Jacob Selhub, Charles S. Fuchs, Jeffrey Meyerhardt, and Edward Giovannucci. 2013. “Prediagnostic Plasma Vitamin B6 (Pyridoxal 5′-Phosphate) and Survival in Patients with Colorectal Cancer.” Cancer Causes & Control 24 (4): 719–29. https://doi.org/10.1007/s10552-013-0152-x.
AbstractHigher plasma pyridoxal 5'-phosphate (PLP) levels are associated with a decreased incidence of colorectal cancer, but the influence of plasma PLP on survival of patients with colorectal cancer is unknown. We prospectively examined whether prediagnostic plasma PLP levels are associated with mortality among colorectal cancer patients.We included 472 incident cases of colorectal cancer identified in the Nurses' Health Study, the Health Professionals Follow-up Study, and the Physicians' Health Study from 1984 to 2002. The patients provided blood samples two or more years before cancer diagnosis. Stratified Cox proportional hazards models were used to calculate hazard ratios (HR) with 95 % confidence intervals (CI) adjusted for other risk factors for cancer survival.Higher plasma PLP levels were not associated with a significant reduction in colorectal cancer-specific (169 deaths) or overall mortality (259 deaths). Compared with patients who had less than 45 pmol/ml of plasma PLP (median: 33.6 pmol/ml), those who had 110 pmol/ml or higher levels (median: 158.8 pmol/ml) had multivariable HRs of 0.85 (95 % CI 0.50-1.45, p trend = 0.37) and 0.87 (95 % CI 0.56-1.35, p trend = 0.24) for colorectal cancer-specific and overall mortality. Higher plasma PLP levels, however, seemed to be associated with better survival among patients who had lower circulating 25-hydroxyvitamin D-3 levels (< 26.5 ng/ml) (p interaction a parts per thousand currency sign.005).Higher prediagnostic plasma PLP levels were not associated with an improvement on colorectal cancer survival overall. Further research is needed to clarify the influence of vitamin B6 on colorectal cancer progression and survival.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:41392014
- SPH Scholarly Articles